Bosh sahifaRUBICON • NSE
add
Rubicon Research Ltd
Yopilish kursi
688,60 ₹
Kunlik diapazon
680,10 ₹ - 697,85 ₹
Yillik diapazon
570,75 ₹ - 754,80 ₹
Bozor kapitalizatsiyasi
112,07 mlrd INR
Oʻrtacha hajm
475,08 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 4,12 mlrd | 39,19% |
Joriy xarajat | 2,03 mlrd | 24,29% |
Sof foyda | 538,52 mln | 56,19% |
Sof foyda marjasi | 13,07 | 12,19% |
Har bir ulushga tushum | 3,47 | — |
EBITDA | 976,82 mln | 48,90% |
Amaldagi soliq stavkasi | 24,90% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,51 mlrd | 90,52% |
Jami aktivlari | 17,82 mlrd | — |
Jami passivlari | 11,35 mlrd | — |
Umumiy kapital | 6,47 mlrd | — |
Tarqatilgan aksiyalar | 154,30 mln | — |
Narxi/balansdagi bahosi | 16,41 | — |
Aktivlardan daromad | 12,02% | — |
Kapitaldan daromad | 17,38% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 538,52 mln | 56,19% |
Operatsiyalardan naqd pul | 605,38 mln | 113,79% |
Sarmoyadan naqd pul | -211,35 mln | -28,03% |
Moliyadan naqd pul | 10,23 mln | 105,42% |
Naqd pulning sof oʻzgarishi | 394,74 mln | 838,52% |
Boʻsh pul | 388,65 mln | — |
Haqida
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, a manufacturing plant located in Ambernath, India, and a regulatory office in Plainsboro, US. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
1 141
